Generic Peptides NAD+ 100 to 750 mg Lyophilized Vials for Sale

Generic Peptides NAD+ - 100 to 750 mg Lyophilized Vials

Generic Peptides NAD+ is nicotinamide adenine dinucleotide, a coenzyme found in every living cell and supplied as a lyophilized powder in four vial sizes: 100 mg, 250 mg, 500 mg and 750 mg. Although it sits on the peptide shelf, NAD+ is a dinucleotide, not a peptide. It carries electrons in the reactions that make cellular energy, and buy NAD+ in the size that fits your study, pairing it with a longevity partner such as Epitalon.

• Four vial sizes - 100 mg to 750 mg
• Lyophilized powder - needs a solvent
• GMP-manufactured - HPLC-verified per batch, COA on file
• U.S. domestic and international shipping

Variant Comparison

All four vials hold the same NAD+ and differ only in the total amount of the coenzyme. The dose is measured in milligrams, and the vial size sets how many divided doses one reconstitution can supply.

The only real difference is supply per vial: a 100 mg vial suits a single small batch, while the 750 mg vial gives the most divided doses from one reconstitution. When the design targets oxidative stress, Glutathione is the usual companion, and a metabolic arm adds 5-Amino-1MQ.

How NAD+ Works

NAD+ accepts electrons and becomes NADH, and that exchange is central to the reactions that build ATP, the cell's energy currency. The same coenzyme is a substrate for the sirtuin deacetylases, studied in relation to ageing, and for PARP enzymes that help repair DNA. Cellular NAD+ levels decline with age, and the body rebuilds the pool through the salvage pathway from nicotinamide and NMN.

Reconstitution & Storage

NAD+ ships as a powder dissolved with sterile or bacteriostatic water, not part of the pack. Divide the milligrams on the vial by the millilitres added to get mg per mL; 100 mg in 2 mL gives 50 mg/mL, and one unit on a U-100 barrel equals 0.01 mL. Keep the powder at 2-8 C, away from light. Once mixed, keep it at 2-8 C and use it within 28 to 30 days.

Dosage & Administration

NAD+ has no approved drug status. In clinics it is given as an intravenous infusion, and the reported reactions depend on the speed of delivery more than the total amount. Flushing, chest tightness, nausea, headache and soreness at the site are common, and slowing the infusion reduces them. Published data on repeated subcutaneous use is limited. Other compounds in the same line include Semax and Thymosin Alpha-1.

Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use.

For laboratory research only. Consult a healthcare professional before handling any compound. Amounts shown are research references, not recommended human doses.